245 Users Online
Antiretroviral Therapy Market
Antiretroviral therapy is a medication which is used in the treatment of HIV. Antiretroviral therapy do not kill the virus, instead it slows down the growth of the virus and so is the HIV disease itself. HIV is continued to be one of the major public health issue globally. According to the report published by WHO in July 2019, 770 000 people have died of HIV related causes globally in the year 2018. Market players are trying to expand the therapeutic application of antiretroviral therapy thus creating more opportunity and scope for the growth of the antiretroviral therapy market in the future.
Rising prevalence rate of HIV is one of the major factors driving growth of the antiretroviral therapy market. Also, increasing adoption of antiretroviral therapy coverage rate and availability of the antiretroviral therapy medication is another factors surging the growth of the antiretroviral therapy market. The increasing research and development activities for developing better therapy for HIV is aiding in growth of the antiretroviral therapy market.
Moreover, decreased cost of treatment and improved diagnosis rate is anticipated to boost the growth of the antiretroviral therapy market. Growing awareness of people for early treatment of the HIV or AIDS is further supporting the antiretroviral therapy market. New drug launches and products in pipeline for HIV treatment is further expected to drive growth of the antiretroviral therapy.
Furthermore, favorable steps taken by government and NGOs to provide treatment for diseases like HIV is boosting the growth of the antiretroviral therapy. However, there are several side effects associated with the therapy thus hampering the growth of the antiretroviral therapy market.
|route of administration||